ABCSG P02

A prospective randomized phase II trial of FOLFIRINOX alone versus FOLFIRINOX followed by radiochemotherapy in patients with locally advanced, primarily inoperable pancreatic cancer.

Start: 05/2017
Coordinating Investigator: Schindl, Martin; Vienna
Kornek, Gabriela; Vienna
Döller, Carmen; Graz
Sample size: 112
Design:
(Click to enlarge)
ABCSG P02

 

Link for studyteam-members only

Further information about this trial

Access to these informations only with keyword. If required, please ask the responsible project manager.